Patent US4134973A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4134973A Expired / Lapsed US ⏱️ 0.0 years remaining

Carbohydrate derivatives of milbemycin and processes therefor

Assignee: Merck and Co Inc
•
Filing: 1977-04-11
•
Granted: 1979-01-16
•
Expires: 1997-04-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Carbohydrate derivatives of the antibiotic substance milbemycin, also identified as B-41, and of 13-hydroxy milbemycin are prepared. The carbohydrate groups are attached to the available hydroxy groups of milbemycin and to the hydroxy group synthesized at the 13-position. The reactions may be made selectively such that more than one carbohydrate group may be attached to a single position, or that multiple carbohydrate groups may be attached at different positions on the molecule. The described carbohydrate derivatives have antiparasitic activity.

Inventors

  • 👤 Michael H. Fisher
  • 👤 Richard L. Tolman

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 18:38
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/12; C07D493/20; C07H; C07H17/00; C07H17/04; C07H17/08

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 133 words
A compound having the formula: ##STR7## wherein R 1 ', R 2 and R 3 have the following definitions: ______________________________________ R'.sub.1 R.sub.2 R.sub.3 ______________________________________ H or sugar CH.sub.3 CH.sub.3 H or sugar CH.sub.3 C.sub.2 H.sub.5 CH.sub.3 CH.sub.3 CH.sub.3 CH.sub.3 CH.sub.3 C.sub.2 H.sub.5 H or sugar ##STR8## CH.sub.3 H or sugar ##STR9## C.sub.2 H.sub.5 ______________________________________ and independently, R 4 ' is hydrogen, hydroxy or a sugar connected to the substrate molecule through an oxygen atom; and R 5 is hydrogen or a sugar, provided at least one of R 1 ' , R 4 ' or R 5 is a sugar and wherein the sugar is a mono-, di- or trisaccharide selected from glucopyranosyl, galactopyranosyl, mannopyranosyl, maltosyl, arabinopyranosyl, lyxopyranosyl, xylopyranosyl, ribopyranosyl, oleandrosyl, rhamnopyranosyl, fucopyranosyl, lactosyl, ribofuranosyl, mannofuranosyl, glucofuranosyl, arabinofuranosyl, mycarosyl, cladinosyl, desosaminosyl, damnosaminosyl, mycaminosyl.
Claim 2
Dependent Claim 133 words
A compound having the formula: ##STR7## wherein R 1 ', R 2 and R 3 have the following definitions: ______________________________________ R'.sub.1 R.sub.2 R.sub.3 ______________________________________ H or sugar CH.sub.3 CH.sub.3 H or sugar CH.sub.3 C.sub.2 H.sub.5 CH.sub.3 CH.sub.3 CH.sub.3 CH.sub.3 CH.sub.3 C.sub.2 H.sub.5 H or sugar ##STR8## CH.sub.3 H or sugar ##STR9## C.sub.2 H.sub.5 ______________________________________ and independently, R 4 ' is hydrogen, hydroxy or a sugar connected to the substrate molecule through an oxygen atom; and R 5 is hydrogen or a sugar, provided at least one of R 1 ' , R 4 ' or R 5 is a sugar and wherein the sugar is a mono-, di- or trisaccharide selected from glucopyranosyl, galactopyranosyl, mannopyranosyl, maltosyl, arabinopyranosyl, lyxopyranosyl, xylopyranosyl, ribopyranosyl, oleandrosyl, rhamnopyranosyl, fucopyranosyl, lactosyl, ribofuranosyl, mannofuranosyl, glucofuranosyl, arabinofuranosyl, mycarosyl, cladinosyl, desosaminosyl, damnosaminosyl, mycaminosyl.
Claim 3
Dependent Claim 20 words
The compounds of claim 1 wherein the sugar is a mono or disaccharide selected from glucopyranosyl, rhamnopyranosyl, oleandrosyl and daunosaminosyl.
Claim 4
Dependent Claim 18 words
The compound of claim 2 wherein the sugar is a mono or disaccharide selected from glucopyranosyl and oleandrosyl.
Claim 5
Dependent Claim 12 words
A compound of claim 3 which is 13-(β-D-glucopyranosyloxy) milbemycin B 2 .
Claim 6
Dependent Claim 12 words
A compound of claim 3 which is 5-O-(β-D-glucopyranosyl) milbemycin A 3 .
Claim 7
Dependent Claim 26 words
A method for the treatment of parasitic infections, which comprises administering to an animal infected with parasites an effective amount of a compound of claim 1.

References Cited (Backward Citations)

US3356674A Cited
US3950360A Cited
US3984564A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-01-15 1982-07-17 1983-01-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-01-15 1986-07-17 1987-01-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-01-15 1990-07-17 1991-01-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag